| Drug Name: | Progabide (62666-20-0) |
|---|---|
| PubChem ID: | 6850568 |
| SMILES: | C1=CC(=CC=C1C(=C2C=C(C=CC2=O)F)NCCCC(=O)N)Cl |
| InchiKey: | DWEQWXSKOHHBNT-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 334.778 |
| LogP | : | 2.8985 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 72.19 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Phenytoin (57-41-0) | Serum Phenytoin Level Increased | Synergistic | Uncertain | Effect of progabide on serum phenytoin and carbamazepine concentrations |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|